IGF-1 is not related to long-term outcome in hyperglycemic acute coronary syndrome patients.
Cindya P IswandiVictor J van den BergSuat SimsekDaan van VelzenEdwin Ten BoekelJan-Hein CornelSanneke de BoerMaarten de MulderK Martijn AkkerhuisEric BoersmaVictor A UmansIsabella KardysPublished in: Diabetes & vascular disease research (2022)
IGF-1 carries potential for predicting type 2 diabetes, rather than long-term cardiovascular outcomes and post-ACS myocardial infarct size and dysfunction, in hyperglycemic ACS patients.
Keyphrases
- acute coronary syndrome
- type diabetes
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- cardiovascular disease
- left ventricular
- heart failure
- oxidative stress
- risk assessment
- insulin resistance
- adipose tissue
- metabolic syndrome
- percutaneous coronary intervention
- antiplatelet therapy
- coronary artery disease
- skeletal muscle
- pi k akt
- drug induced
- growth hormone